Robles-Zurita, José ;
Boyd, Kathleen A ;
Briggs, Andrew H...
Robles-Zurita , J , Boyd , K A , Briggs , A H , Iveson , T , Kerr , R S , Saunders , M P , Cassidy , J , Hollander , N H , Tabernero , J , Segelov , E , Glimelius , B , Harkin , A , Allan , K , McQueen , J , Pearson , S , Waterston , A , Medley , L , Wilson , C , Ellis , R , Essapen , S , Dhadda , A S , Hughes , R , Falk , S , Raouf , S , Rees , C , Olesen , R K , Propper , D , Bridgewater , J , Azzabi , A , Farrugia , D , Webb , A , Cunningham , D , Hickish , T , Weaver , A , Gollins , S , Wasan , H S & Paul , J 2018 , ' SCOT : a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer ' , British Journal of Cancer , vol. 119 , no. 11 , pp. 1332-1338 . https://doi.org/10.1038/s41416-018-0319-z.
,
2018
